Glioma cells expressing EGFRvIII were found to recruit EGFR-WT-expressing cells and accelerate glioma tumorigenicity by up-regulating the expression levels of cytokines (e.g., interleukin 6 [IL6] and/or leukemia inhibitory factor) [44]. The gene discussed is EGFR; the disease is central nervous system cancer.